Livzon Pharmaceutical Group Inc (SZSE:000513) Share Price

Company Profile

Business description
Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. As a pharmaceutical manufacturer, the company's portfolio comprises Western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. Its drug addresses serious conditions such as gastrointestinal, cardiovascular, anti-infectious, antimicrobial, antineoplastic, hemopoietic system, and other conditions. It distributes its products within domestic markets and to overseas markets. It operates in a single reportable segment in the PRC which is pharmaceutical manufacturing.
Contact
38 Chuangye North Road
Headquarters Building, Jinwan District
Guangdong Province
Zhuhai519090
CHN
T: +86 7568135888
https://www.livzon.com.cn
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
9,067

Recommended

This Australian success story looks set to face profit margin compression from the scariest of competitors.

Johannes Faul, CFA | 11 August 2025

For individual investors, it is important to frame earnings season revelations in a long-term way.

Joseph Taylor | 11 August 2025

Shares soared 30% in the last week but are still undervalued.

Shane Ponraj, CFA | 11 August 2025

Index	Last price	Change	% Change
All Ordinaries	9,141.70	24.10	0.26%
CAC 40	7,698.52	44.48	-0.57%
DAX 40	24,081.34	81.52	-0.34%
Dow JONES (US)	43,975.09	200.52	-0.45%
FTSE 100	9,129.71	33.98	0.37%
HKSE	24,929.34	22.53	0.09%
NASDAQ	21,385.40	64.62	-0.30%
Nikkei 225	42,969.07	1,148.59	2.75%
NZX 50 Index	12,804.18	107.68	-0.83%
S&P 500	6,373.45	16.00	-0.25%
S&P/ASX 200	8,873.60	28.80	0.33%
SSE Composite Index	3,666.33	18.78	0.51%